Top news of the week: 05.05.2020.

#CoronaVirus #pharmaceuticals #COVID19 #CoronaPandemic #biospace #lifesciences #CoronaOutbreak #biotechnology #Biotech #synbio

Career And Jobs

On May 1, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: May 1 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/Q9R3iDsc1f
Open

Biopharma Update on the Novel Coronavirus: May 1

Biopharma Update on the Novel Coronavirus: May 1

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 1, 2020.

On May 4, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: May 4 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/KNzhMIBJxp
Open

Biopharma Update on the Novel Coronavirus: May 4

Biopharma Update on the Novel Coronavirus: May 4

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 4, 2020.

On May 1, 2020
@biospace shared
The Biopharma Workplace and Coronavirus Insight Report - Part I: Biotech Professionals Feel Isolated In the latest BioSpace Insight Report, we take a look at how biotech professionals adapt to new working conditions amid the pandemic. https://t.co/0kA94Rmfod
Open

During COVID-19, Biotech Professionals Feel Isolated and Less Productive

During COVID-19, Biotech Professionals Feel Isolated and Less Productive

A vaccine for COVID-19 is unlikely to be ready in 2020, according to biopharma professionals responding to the BioSpace Workplace Survey: The Impact of COVID-19 – Spring 2020. Only 25% of ...

On Apr 30, 2020
@CALifeSciences shared
RT @Ginkgo: "It was the right thing to do." https://t.co/USmwHqzYtJ
Open

Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus

Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus

Ginkgo Bioworks has raised $719 million since it launched in 2008 to develop biotechnology solutions for industries as varied as cosmetics, agriculture and pharmaceuticals.

On May 4, 2020
@biospace shared
The Biopharma Workplace and Coronavirus Insight Report - Part II: Biotech Professionals Express Fears… and Hope, During Pandemic #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/dwoiIBm2EY
Open

Biotech Professionals Express Fears…and Hope, During Pandemic

Biotech Professionals Express Fears…and Hope, During Pandemic

While the biopharmaceutical industry is working frantically to develop the tests, vaccines and therapeutics to combat COVID-19, the people doing the work are pushing their fears to one ...

On Apr 30, 2020
@pharminews shared
UK biotech company announces discovery of novel potential Covid-19 treatments https://t.co/NzmxhlsHFs #pharma #news
Open

UK biotech company announces discovery of novel potential Covid-19 treatments

UK biotech company announces discovery of novel potential Covid-19 treatments

ILC Therapeutics, a UK-based biotechnology firm has announced the discovery of two separate novel treatments for Covid-19 patients before they are put on ventilators.  They are now urgently ...

On Apr 29, 2020
@Glassdoor shared
The Best 9 Companies to Work For In New York https://t.co/Z3CmZpCvN1
Open

The Best 9 Companies to Work For In New York

The Best 9 Companies to Work For In New York

Find a new role at one the best companies to work for in New York.

On May 4, 2020
@JohnCendpts shared
Covid-19 roundup: Catalent signs another Covid-19 manufacturing deal https://t.co/uaXUo6CiHY
Open

Covid-19 roundup: Catalent signs another Covid-19 manufacturing deal; Eli Lilly's antibody partner grabs $175M+

Covid-19 roundup: Catalent signs another Covid-19 manufacturing deal; Eli Lilly's antibody partner grabs $175M+

Just a few days after allying itself with pharma giant J&J, the contract manufacturing player Catalent has signed up to do the production work for a small US biotech in the early stages of ...